Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Logo Johnson & Johnson
Johnson & Johnson is a holding company, which is engaged in the research and development, manufacture and sale of a range of products in the healthcare field. It operates through three segments: Consumer, Pharmaceutical and Medical Devices. Its primary focus is products related to human health and well-being. The Consumer segment includes a range of products used in the baby care, oral care, skin care, over-the-counter pharmaceutical, women's health and wound care markets. The Pharmaceutical segment is focused on five therapeutic areas, including immunology, infectious diseases, neuroscience, oncology, and cardiovascular and metabolic diseases. The Medical Devices segment includes a range of products used in the orthopedic, surgery, cardiovascular, diabetes care and vision care fields. Its research facilities are located in the United States, Belgium, Brazil, Canada, China, France, Germany, India, Israel, Japan, the Netherlands, Singapore, Switzerland and the United Kingdom.

Number of employees : 134 500 people.
Sales per Business
20192020Delta
USD (in Million)%USD (in Million)%
Pharmaceutical42,19851.4%45,57255.2% +8%
Medical Devices25,96331.6%22,95927.8% -11.57%
Consumer13,89816.9%14,05317% +1.12%
Sales per region
20192020Delta
USD (in Million)%USD (in Million)%
United States42,09751.3%43,13352.2% +2.46%
Europe18,46622.5%18,98023% +2.78%
Asia-Pacific, Africa15,55518.9%15,13618.3% -2.69%
Western Hemisphere Excluding United States5,9417.2%5,3356.5% -10.2%
Managers
NameAgeSinceTitle
Alex Gorsky592012Chairman & Chief Executive Officer
Joseph Wolk532018Chief Financial Officer & Executive Vice President
Paulus Stoffels592012Chief Scientific Officer
James Swanson-2019Global Chief Information Officer & Executive VP
Charles O. Prince702006Independent Director
Anne M. Mulcahy672012Lead Independent Director
Ronald Williams702011Independent Director
Ian Davis692010Independent Director
A. Eugene Washington, Dr.692012Independent Director
Mark B. McClellan, Dr.562013Independent Director
Members of the board
NameAgeSinceTitle
Alex Gorsky592012Chairman & Chief Executive Officer
Charles O. Prince702006Independent Director
Anne M. Mulcahy672012Lead Independent Director
Ronald Williams702011Independent Director
Ian Davis692010Independent Director
A. Eugene Washington, Dr.692012Independent Director
Mark B. McClellan, Dr.562013Independent Director
D. Davis682014Independent Director
Mary C. Beckerle, Dr.652015Independent Director
Jennifer A. Doudna, Dr.562018Independent Director
Equities
Vote QuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 3,120,537,003 2,631,210,467 84.3% 487,141,000 15.6% 84.3%
Shareholders
NameEquities%
The Vanguard Group, Inc. 218,494,118 8.30%
SSgA Funds Management, Inc. 140,270,595 5.33%
BlackRock Fund Advisors 61,026,749 2.32%
Geode Capital Management LLC 40,825,241 1.55%
State Farm Investment Management Corp. 34,574,792 1.31%
Wellington Management Co. LLP 33,886,162 1.29%
Capital Research & Management Co. 32,520,000 1.23%
Northern Trust Investments, Inc.(Investment Management) 32,058,041 1.22%
Massachusetts Financial Services Co. 27,864,699 1.06%
Norges Bank Investment Management 27,770,786 1.05%
Holdings
NameEquities%Valuation
Adimmune Corporation (4142) 18,715,0004.36%35,457,065 USD
Cryo-Cell International, Inc. (CCEL) 152,7241.91%1,336,335 USD
GRAIL, Inc. 50,868,6717.58%509 USD
Idorsia Ltd (IDIA) 00.0000%
Markets and indexes
-
- International Market
- DJIA / S&P 100, S&P 500, Stoxx Americas 100, Stoxx Global 200, Stoxx NorthAmerica 50, Stoxx USA 50
Company contact information
Johnson & Johnson
1 Plaza Johnson et Johnson
NJ 08933 New Brunswick, New Jersey


Phone : +1 (732) 524 0400
Fax :
web site : http://www.jnj.com
Brand Portfolio
In partnership withAllbrands.markets
More brands of Johnson & Johnson
Sector Other Pharmaceuticals
1st jan.Capitalization (M$)
JOHNSON & JOHNSON4.52%433 167
ROCHE HOLDING AG11.21%330 710
PFIZER, INC.7.55%221 613
NOVARTIS AG0.77%210 689
ABBVIE INC.8.10%204 582
ELI LILLY AND COMPANY32.39%203 185
NOVO NORDISK A/S21.76%194 583
MERCK & CO., INC.-7.46%191 677
ASTRAZENECA PLC13.91%154 316
BRISTOL-MYERS SQUIBB COMPANY8.69%150 538
AMGEN INC.4.32%137 807
SANOFI12.91%134 782
GLAXOSMITHKLINE PLC5.59%99 903
JIANGSU HENGRUI MEDICINE CO., LTD.-23.76%71 480
CHUGAI PHARMACEUTICAL CO., LTD.-17.95%68 012
BAYER AG11.33%63 871
ALLERGAN PLC0.97%63 659
TAKEDA PHARMACEUTICAL COMPANY LIMITED1.15%54 016
DAIICHI SANKYO COMPANY, LIMITED-26.42%45 597
ASTELLAS PHARMA INC.22.43%32 805
EISAI CO., LTD.52.54%29 701